Overview
- Editors:
-
-
J. Verweij
-
Department of Medical Oncology, Rotterdam Cancer Institute, Rotterdam, The Netherlands
-
H. M. Pinedo
-
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands
-
H. D. Suit
-
Department of Radiation Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
Access this book
Other ways to access
Table of contents (14 chapters)
-
-
- Martin Harris, Ann L. Hartley
Pages 1-8
-
-
- Colin S. Cooper, Paul Cornes
Pages 31-50
-
- Floro Miraldi, Lee P. Adler, Peter Faulhaber
Pages 51-64
-
-
-
- Herman D. Suit, Ira J. Spiro, Matthew Spear
Pages 95-105
-
- Phillip M. Devlin, Louis B. Harrison
Pages 107-128
-
- Clive Harmer, Margaret Bidmead
Pages 129-141
-
- Ira J. Spiro, Herman D. Suit
Pages 143-155
-
-
- Jaap Verweij, Herbert M. Pinedo
Pages 173-187
-
- A. M. M. Eggermont, H. Schraffordt Koops, J. M. Klausner, P. M. Schlag, B. B. R. Kroon, G. Ben-Ari et al.
Pages 189-203
-
- Alberto S. Pappo, Charles B. Pratt
Pages 205-222
-
Back Matter
Pages 223-232
About this book
The previous volumes in this series on soft tissue sarcomas highlighted the importance of the multidisciplinary approach to treatment, and this focus is continued in the present volume. Proper diagnosis and staging remain the cornerstone of the treatment strategy. Sophisticated histopathology tech niques and growing consensus on grading systems have further increased the importance of the histopathologist in providing estimates of patient prognosis as well as in providing data for planning the treatment strategy. The use of cytogenetics in this field is rapidly increasing and might enable the distinction of subgroups in specific histological tumor types. Furthermore, molecular biological studies not only help reveal inherited predispositions and details in tumor oncogenesis, but they may also provide additional predictive factors for tumor behavior. Further data on treatment strategy will be provided by diag nostic imaging, and in this volume the value of PET imaging, a relatively new achievement, is highlighted. As far as the actual treatment is concerned, surgery still provides the major opportunity for cure. The addition of radiotherapy to surgery is of utmost importance in efforts to spare as much tissue as possible. The chapters on the planning of radiotherapy, brachytherapy, and the treatment of benign soft tissue lesions using radiotherapy are new contributions to this book. One of the potential late problems of radiotherapy is the occurrence of secondary soft tissue sarcomas, which is discussed in Chapter 10.
Editors and Affiliations
-
Department of Medical Oncology, Rotterdam Cancer Institute, Rotterdam, The Netherlands
J. Verweij
-
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands
H. M. Pinedo
-
Department of Radiation Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
H. D. Suit